VYNE Therapeutics Inc.VYNENASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank60
3Y CAGR-61.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-61.1%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 2.83% |
| 2024 | -34.52% |
| 2023 | 13.22% |
| 2022 | 48.20% |
| 2021 | 58.91% |
| 2020 | -110.71% |
| 2019 | -23.15% |
| 2018 | -87.00% |
| 2017 | -1117.66% |
| 2016 | 44.49% |